Tsai T P, Chaux A, Matloff J M, Kass R M, Gray R J, DeRobertis M A, Khan S S
Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Ann Thorac Surg. 1994 Aug;58(2):445-50; discussion 450-1. doi: 10.1016/0003-4975(94)92225-x.
Five hundred twenty-eight consecutive patients aged 80 years and over (mean age, 83.1 +/- 2.7 years) underwent cardiac operations with hypothermia (mean, 21.9 degrees +/- 2.2 degrees C), hyperkalemic cardioplegia, and cardiopulmonary bypass in a 10-year period. Fifty-six percent of the patients were male. Preoperatively, 68% of the patients were in New York Heart Association functional class IV, and 31% were in class III. Among them, 303 patients had isolated coronary artery bypass grafting (CABG) (group I), 132 had aortic valve replacement only or combined with CABG (group II), 42 had mitral valve replacement only or combined with CABG (group III), 31 had mitral valve repair and CABG (group IV), and 20 had double-valve procedure only or combined with CABG (group V). The 30-day or in-hospital mortality was 8.3% in group I, 4.5% in group II, 29% in group III, 23% in group IV, and 30% in group V. Total 30-day or in-hospital mortality was 10.6%. One-year and 5-year actuarial survival rates were as follows: group I, 82% and 62%; group II, 85% and 58%; group III, 61% and 37%; group IV, 56% and 19%; and group V, 63% and 15%. Total 1-year and 5-year actuarial survival were 79% and 54%. At follow-up (mean, 2 years), 70% of overall survivors reported that their general health had improved. Our experience demonstrates that for select patients aged 80 years and over with unmanageable cardiac symptoms, CABG and aortic valve replacement groups had better results in improving quality of life as compared with patients having mitral or combined procedures.
在10年期间,528例连续的80岁及以上患者(平均年龄83.1±2.7岁)接受了低温(平均21.9℃±2.2℃)、高钾停搏液和体外循环下的心脏手术。56%的患者为男性。术前,68%的患者纽约心脏协会心功能分级为IV级,31%为III级。其中,303例患者仅接受了冠状动脉旁路移植术(CABG)(I组),132例仅接受主动脉瓣置换术或联合CABG(II组),42例仅接受二尖瓣置换术或联合CABG(III组),31例接受二尖瓣修复和CABG(IV组),20例仅接受双瓣膜手术或联合CABG(V组)。I组30天或住院死亡率为8.3%,II组为4.5%,III组为29%,IV组为23%,V组为30%。30天或住院总死亡率为10.6%。1年和5年精算生存率如下:I组为82%和62%;II组为85%和58%;III组为61%和37%;IV组为56%和19%;V组为63%和15%。1年和5年总精算生存率分别为79%和54%。在随访(平均2年)时,70%的总体幸存者报告其总体健康状况有所改善。我们的经验表明,对于80岁及以上有难以控制的心脏症状的特定患者,与接受二尖瓣或联合手术的患者相比,CABG和主动脉瓣置换组在改善生活质量方面有更好的结果。